04:43 PM EDT, 06/21/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Friday it received approval from the European Commission for Fruzaqla for the treatment of previously treated metastatic colorectal cancer.
The company secured the US Food and Drug Administration's approval of Fruzaqla as colorectal cancer treatment in November.